269 related articles for article (PubMed ID: 33023606)
1. Biomarkers for antimicrobial stewardship: a reappraisal in COVID-19 times?
van Berkel M; Kox M; Frenzel T; Pickkers P; Schouten J;
Crit Care; 2020 Oct; 24(1):600. PubMed ID: 33023606
[No Abstract] [Full Text] [Related]
2. Procalcitonin as an antibiotic stewardship tool in COVID-19 patients in the intensive care unit.
Heesom L; Rehnberg L; Nasim-Mohi M; Jackson AIR; Celinski M; Dushianthan A; Cook P; Rivinberg W; Saeed K
J Glob Antimicrob Resist; 2020 Sep; 22():782-784. PubMed ID: 32717489
[No Abstract] [Full Text] [Related]
3. COVID-19: don't neglect antimicrobial stewardship principles!
Huttner BD; Catho G; Pano-Pardo JR; Pulcini C; Schouten J
Clin Microbiol Infect; 2020 Jul; 26(7):808-810. PubMed ID: 32360446
[No Abstract] [Full Text] [Related]
4. Antibiotic stewardship: Early discontinuation of antibiotics based on procalcitonin level in COVID-19 pneumonia.
Roy A; Powers HR; Craver EC; Nazareno MD; Yarrarapu SNS; Sanghavi DK
J Clin Pharm Ther; 2022 Feb; 47(2):243-247. PubMed ID: 34766357
[TBL] [Abstract][Full Text] [Related]
5. Procalcitonin as a biomarker for ventilator associated pneumonia in COVID-19 patients: Is it an useful stewardship tool?
Côrtes MF; de Almeida BL; Espinoza EPS; Campos AF; do Nascimento Moura ML; Salomão MC; Boszczowski I; Freire MP; de Carvalho LB; Paranhos-Baccalà G; Costa SF; Guimarães T
Diagn Microbiol Infect Dis; 2021 Oct; 101(2):115344. PubMed ID: 34243136
[TBL] [Abstract][Full Text] [Related]
6. Coronavirus Disease 2019 Sepsis: A Nudge Toward Antibiotic Stewardship.
Coz Yataco AO; Simpson SQ
Chest; 2020 Nov; 158(5):1833-1834. PubMed ID: 32707181
[No Abstract] [Full Text] [Related]
7. Procalcitonin in patients with severe coronavirus disease 2019 (COVID-19): A meta-analysis.
Lippi G; Plebani M
Clin Chim Acta; 2020 Jun; 505():190-191. PubMed ID: 32145275
[No Abstract] [Full Text] [Related]
8. Laboratory Findings in SARS-CoV-2 Infections in Zigong, China: Key Points for Serum Prealbumin.
Guo X; Liu W; Zhong J; Yin M; Zhang C
Clin Lab; 2020 Jun; 66(6):. PubMed ID: 32538056
[No Abstract] [Full Text] [Related]
9. Role of biomarkers in antimicrobial stewardship: physicians' perspectives.
Seok H; Park DW
Korean J Intern Med; 2024 May; 39(3):413-429. PubMed ID: 38715231
[TBL] [Abstract][Full Text] [Related]
10. SARS-CoV-2-Induced Immune Dysregulation and Myocardial Injury Risk in China: Insights From the ERS-COVID-19 Study.
Li D; Chen Y; Jia Y; Tong L; Tong J; Wang W; Liu Y; Wan Z; Cao Y; Zeng R
Circ Res; 2020 Jul; 127(3):397-399. PubMed ID: 32375560
[No Abstract] [Full Text] [Related]
11. Clinical Characteristics and Outcomes of Hospitalized and Critically Ill Children and Adolescents with Coronavirus Disease 2019 at a Tertiary Care Medical Center in New York City.
Chao JY; Derespina KR; Herold BC; Goldman DL; Aldrich M; Weingarten J; Ushay HM; Cabana MD; Medar SS
J Pediatr; 2020 Aug; 223():14-19.e2. PubMed ID: 32407719
[TBL] [Abstract][Full Text] [Related]
12. COVID-19 will further exacerbate global antimicrobial resistance.
Yam ELY
J Travel Med; 2020 Sep; 27(6):. PubMed ID: 32539142
[No Abstract] [Full Text] [Related]
13. Tackling antimicrobial resistance in the COVID-19 pandemic.
Getahun H; Smith I; Trivedi K; Paulin S; Balkhy HH
Bull World Health Organ; 2020 Jul; 98(7):442-442A. PubMed ID: 32742026
[No Abstract] [Full Text] [Related]
14. Will coronavirus disease (COVID-19) have an impact on antimicrobial resistance?
Monnet DL; Harbarth S
Euro Surveill; 2020 Nov; 25(45):. PubMed ID: 33183403
[No Abstract] [Full Text] [Related]
15. Evaluation of procalcitonin as a contribution to antimicrobial stewardship in SARS-CoV-2 infection: a retrospective cohort study.
Williams EJ; Mair L; de Silva TI; Green DJ; House P; Cawthron K; Gillies C; Wigfull J; Parsons H; Partridge DG
J Hosp Infect; 2021 Apr; 110():103-107. PubMed ID: 33484783
[TBL] [Abstract][Full Text] [Related]
16. Repurposing antimicrobial stewardship tools in the electronic medical record for the management of COVID-19 patients.
Davis MW; McManus D; Koff A; Jaszczur GR; Malinis M; Dela Cruz C; Britto CJ; Price C; Azmy V; Kaman K; Gaston D; Early K; DeWitt M; Song JS; Ortiz C; Juthani-Mehta M; Topal JE
Infect Control Hosp Epidemiol; 2020 Nov; 41(11):1335-1337. PubMed ID: 32507113
[TBL] [Abstract][Full Text] [Related]
17. Eosinophil count in severe coronavirus disease 2019.
Lippi G; Henry BM
QJM; 2020 Jul; 113(7):511-512. PubMed ID: 32315429
[No Abstract] [Full Text] [Related]
18. The use of procalcitonin as an antimicrobial stewardship tool and a predictor of disease severity in coronavirus disease 2019 (COVID-19).
Drewett GP; Smibert OC; Holmes NE; Trubiano JA
Infect Control Hosp Epidemiol; 2022 Apr; 43(4):542-543. PubMed ID: 33487208
[No Abstract] [Full Text] [Related]
19. Characteristics and outcomes of diabetic patients infected by the SARS-CoV-2.
Elamari S; Motaib I; Zbiri S; Elaidaoui K; Chadli A; Elkettani C
Pan Afr Med J; 2020; 37():32. PubMed ID: 33209159
[TBL] [Abstract][Full Text] [Related]
20. Collateral damage of the COVID-19 pandemic: Exacerbation of antimicrobial resistance and disruptions to antimicrobial stewardship programmes?
Chibabhai V; Duse AG; Perovic O; Richards GA
S Afr Med J; 2020 Jun; 110(7):572-573. PubMed ID: 32880323
[No Abstract] [Full Text] [Related]
[Next] [New Search]
